ALICE AUBEL: Open Payments
NPI 1801906888 · EVANSTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,666 in 87 payments from 18 companies in 2025. Trend: 2023 $2,087 · 2024 $2,855 · 2025 $2,666
Food & beverage: $2,666
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $427 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $353 |
| AstraZeneca Pharmaceuticals LP | 14 | $310 |
| Novartis Pharmaceuticals Corporation | 13 | $270 |
| Amgen Inc. | 3 | $266 |
| Abbott Laboratories | 4 | $206 |
| BridgeBio Pharma, Inc. | 4 | $203 |
| Janssen Pharmaceuticals, Inc | 7 | $142 |
| Boston Scientific Corporation | 4 | $102 |
| PFIZER INC. | 5 | $95 |
Products named: JARDIANCE, Wegovy, LEQVIO, FARXIGA, REPATHA, Attruby, CARDIOMEMS, Ozempic.
Industry payments across IL — which companies pay providers there.
